Accelerating cell therapy discovery & development with non-viral gene engineering
Xiaobai Patrinostro, David Hermanson, Scott Silaika
12 September 2022
Innovator Insight
“This is not a sustainable model.”
Joe DePinto, Robert Richards
21 February 2022
Innovator Insight
Gain deeper insights into the mechanisms of immune cell killing of tumor cells: accelerate your time to answer with integrated software analysis
N Bevan, T Dale, J Skolnik et al
08 December 2021
Innovator Insight
Preparing for pivotal: solving challenges in scale for cell and gene therapy clinical trials
S Viswanathan, R Gaeto, E Goodhue Meyer et al
06 August 2021
Innovator Insight
Evolving the role of gene editing in cell therapy
Jonathan Frampton, Torsten Meissner, Tristan Thwaites
29 October 2020
Innovator Insight
FectoVIR®-AAV: a giant step for AAV large scale manufacturing
A Nyamay'antu, M Hellal, M Porte et al
28 May 2020
Innovator Insight
Automation: what will the cell therapy laboratory of the future look like?
Wenyan Leong, Brian Nankervis, Jim Beltzer
02 January 2019
Innovator Insight
Commercial Lessons for Clinical Success
Simon Ellison, Heidi Hagen, Christophe Suchet
19 December 2018
Innovator Insight
The importance of material selection in the differentiation of monocytes into dendritic cells
Natasha Boghosian, Robert Pleydon, David Smith
27 November 2018
Innovator Insight
Utilization of Recombinant Albumins in the Expansion of Human T Lymphocytes
Atherly Pennybaker, Randall Alfano
29 May 2018
Innovator Insight
The Importance of Collection, Processing & Biopreservation Best Practices in Determining CAR-T Starting Material Quality
Lou Juliano, George Eastwood
29 May 2018
Innovator Insight